CS MEDICA Expands Presence in Eastern Europe through New Partnership news.cision.com/cs-medica-a-… via @cision
1
106
CS MEDICA A/S: Update on the Strategic Rationale Behind CANNORDIC IPO and Aim for Capital Increase news.cision.com/cs-medica-a-… via @cision
70
CS MEDICA Valued at 17,16 DKK (€2.30 ) per Share Ahead of German IPO, Highlighting Unique Regulatory Position and Growth Potential
A new valuation report conducted by NuWays as a third-party firm, commissioned and funded by CS MEDICA.
news.cision.com/cs-medica-a-… via @cision
51
CS MEDICA Achieves Key Milestone in MDR Compliance with Finalized Classification, Solidifying Unique Market Position for Medical Devices news.cision.com/cs-medica-a-… via @cision
37
CS MEDICA's Subsidiary Signs Agreement to Target the German Market, Leveraging Expertise of Nimbus Health, a Dr. Reddy's Laboratories company. news.cision.com/cs-medica-a-… via @cision
58
CS MEDICA A/S Update from CEO: Strategic Developments on CANNORDIC Planned IPO Milestones news.cision.com/cs-medica-a-… via @cision
40
CS MEDICA A/S Announces Strategic Partnership with Scan MedPartners to Expand Reach into the US Market news.cision.com/cs-medica-a-… via @cision
24
CS MEDICA Announces Approval of CANNASEN® Pain Patch in Malaysia and Trademark Registration in Thailand news.cision.com/cs-medica-a-… via @cision
30
CS MEDICA Achieves MDR Classification, Setting New Standards in Substance-Based Medical Devices news.cision.com/cs-medica-a-… via @cision
32
CS MEDICA Pioneers CBD-Infused Medical Devices in Jordan with Confirmed Classification news.cision.com/cs-medica-a-… via @cision
25
CS MEDICA Q3 2023/2024 Results: Strong Revenue Growth of 400% Despite Production Delays news.cision.com/cs-medica-a-… via @cision
21
CS MEDICA receives 2 MDKK to support its short-term financial obligations.
news.cision.com/cs-medica-a-…
4
62
CS MEDICA publishes its H1 report 2023/2024. Highlights from the report will be presented at a live-streamed conference on Thursday, May 23, at 15:00 CET.
news.cision.com/cs-medica-a-…
47
CS MEDICA A/S announces today that CEO, Lone Henriksen has acquired in total of 7.610 shares in CS MEDICA at an average price of DKK 4,16, amounting to a total value of DKK 31.628,35.
news.cision.com/cs-medica-a-…
2
73
CS MEDICA A/S, a first mover in CBD-based registered substance-based medical devices, forms a partnership with 180˚ Drug Store to penetrate Germany and key markets in the Gulf Cooperation Council (GCC) with a potential of 440,000 Units in the First Year.
news.cision.com/cs-medica-a-…
2
34
CS MEDICA releases its Q report for the period October – December 2023. Highlights of the period will be presented at a live-streamed conference call on Friday the 5th of April at 11 AM CET. T
#QReport #Q42023 #cannabisindustri #MedTech #CSMED #WebCal
news.cision.com/cs-medica-a-…
3
65
AGM has now been finalized covering the annual year 2022/2023 - please find the minutes below.
news.cision.com/cs-medica-a-…
40
As a follow-up to our Annual Report, we have issued a Letter from the CEO, regarding CS MEDICA's 2024 Progress Report, please see the below link;
news.cision.com/cs-medica-a-…
30
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN® into Jordan
news.cision.com/cs-medica-a-…
4
22
CS MEDICA A/S: Notice of Shareholders’ Annual General Meeting
news.cision.com/cs-medica-a-…
31
